Chitosan as a novel nasal delivery system for vaccines (Q34343257)

1 August 2017

1 reference

title

Chitosan as a novel nasal delivery system for vaccines (English)

1 reference

1 August 2017

Illum L

1

1 reference

1 August 2017

Jabbal-Gill I

2

1 reference

1 August 2017

Hinchcliffe M

3

1 reference

1 August 2017

Fisher AN

4

1 reference

1 August 2017

Davis SS

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

81-96

1 reference

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Immunology of the tonsils.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Crystallized dextran nanospheres with entrapped antigen and their use as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Polymer-grafted starch microparticles for oral and nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Bioadhesive microspheres as a potential nasal drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Chitosan and its use as a pharmaceutical excipient

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Effect of chitosan on epithelial permeability and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Clearance characteristics of chitosan based formulations in the sheep nasal cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900171-5

7 January 2021

10.1016/S0169-409X(01)00171-5

Identifiers

DOI

1 reference

1 August 2017

1 reference